CDC and the Food and Drug Administration (FDA) will cosponsor
the first International Latex Conference November 5-7, 1992, in
Baltimore. The conference will provide an opportunity for
health-care professionals, scientists, industry, and regulatory
agencies to present data and exchange information about the issues
of hypersensitivity reaction to latex medical devices. The program
will include speakers, oral and poster presentations, and a panel
discussion. Topics will include latex chemistry, clinical studies,
protein quantification and identification, epidemiology of latex
hypersensitivity, diagnostic testing methods, prevention
strategies, and approaches of manufacturers and producers.
Additional information is available from the FDA International
Latex Conference, in care of Crosspaths Management Systems, Inc.,
Two Wisconsin Circle, Suite 660, Chevy Chase, MD 20815; telephone
(800) 5CPATHS ((800) 527-2847).
Disclaimer
All MMWR HTML documents published before January 1993 are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.
